Press Releases
Recruitment for 30 new PhD pandemic research scholarships opens today at University of Warwick thanks to over £3 million in donations.
The search for 30 people to take up new PhD pandemic research scholarships begins today (Friday 19th March 2021) thanks to philanthropists donating to the University of Warwick’s newly created Institute for Global Pandemic Planning. The 30 new doctoral students will research the best ways for global leaders to respond to pandemics and more details on how to apply are available here: https://warwick.ac.uk/fac/cross_fac/igpp/applicationform
How bacterial traffic jams lead to antibiotic-resistant, multilayer biofilms
New insight on the physical interactions that take place between swarming bacteria when exposed to antibiotics could lead to novel approaches for treating infections in patients.
University of Warwick signs agreement with agronomy specialist to bring UK beans to market
The University of Warwick’s research commercialisation wing, Warwick Innovations, has signed a contract with agronomy specialist Agrii to promote the commercial production of UK haricot beans developed by scientists at the University of Warwick.
Chemical memory in plants affects chances of offspring survival
Researchers at the University of Warwick have uncovered the mechanism that allows plants to pass on their ‘memories’ to offspring, which results in growth and developmental defects.
Diabetic drug could slow the progression of Parkinson’s disease
· A hallmark of Parkinson's disease is the degeneration of a group of neurons in the brain that release the neurotransmitter dopamine (dopaminergic neurons). By introducing low concentrations of structurally-defined aggregates of alpha synuclein, a key toxic species in Parkinson’s disease, into single dopaminergic neurons, researchers from the University of Warwick have shown these protein aggregates open a specific channel in the cell membrane, reducing neuronal excitability. Furthermore they’ve shown that this can be partially prevented by pre-application of the commonly used anti-diabetic drug, glibenclamide.
Breakthrough in studying the enzyme that ultimately produces fish odour syndrome
Fish odour syndrome (trimethylaminuria) is a debilitating disease, in which the liver cannot break down the smelly chemical trimethylamine which is produced by enzymes from bacteria residing in the gut leaving people with a fish like odour. Researchers from the University of Warwick are paving the way to prevent the syndrome after a breakthrough in studying the enzyme in the gut which produces trimethylamine.